1 | GSM1289436 | PBMCs vs. PBMCs treated with TNF-a from 10 pooled healthy donors - technical replicate 1 | primary culture: ex vivo PBMCs from pooled 10 healthy donors |
2 | GSM1289437 | PBMCs vs. PBMCs treated with TNF-a from 10 pooled healthy donors - technical replicate 2 | primary culture: ex vivo PBMCs from pooled 10 healthy donors |
3 | GSM1289438 | PBMCs vs. PBMCs treated with TNF-a from 10 pooled healthy donors - technical replicate 3 | primary culture: ex vivo PBMCs from pooled 10 healthy donors |
1 | GSM1289439 | PBMCs vs. PBMCs treated with EPO-a from 10 pooled healthy donors - technical replicate 1 | primary culture: ex vivo PBMCs from pooled 10 healthy donors |
2 | GSM1289440 | PBMCs vs. PBMCs treated with EPO-a from 10 pooled healthy donors - technical replicate 2 | primary culture: ex vivo PBMCs from pooled 10 healthy donors |
3 | GSM1289441 | PBMCs vs. PBMCs treated with EPO-a from 10 pooled healthy donors - technical replicate 3 | primary culture: ex vivo PBMCs from pooled 10 healthy donors |
1 | GSM1289442 | PBMCs vs. PBMCs treated with TNF-a and EPO-a from 10 pooled healthy donors - technical replicate 1 | primary culture: ex vivo PBMCs from pooled 10 healthy donors |
2 | GSM1289443 | PBMCs vs. PBMCs treated with TNF-a and EPO-a from 10 pooled healthy donors - technical replicate 2 | primary culture: ex vivo PBMCs from pooled 10 healthy donors |
3 | GSM1289444 | PBMCs vs. PBMCs treated with TNF-a and EPO-a from 10 pooled healthy donors - technical replicate 3 | primary culture: ex vivo PBMCs from pooled 10 healthy donors |